AG˹ٷ

STOCK TITAN

[6-K] Haleon plc American Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

On 05 Aug 2025, Haleon plc (HLN) filed a Form 6-K confirming execution of the second tranche of its share-buyback programme announced 31 Jul 2025. On 04 Aug 2025 the company repurchased 1,418,324 ordinary shares on the London Stock Exchange for cancellation. Purchase prices ranged from 355.90p to 364.60p, with a volume-weighted average of 358.534p. After settlement, issued share capital stands at 8,984,952,236 shares of £0.01 each; 3,880,205 shares are held in treasury, leaving 8,981,072,031 shares entitled to vote. A detailed trade log is available via the LSE RNS link and on Haleon’s investor site. No additional financial results or forward guidance were provided.

Il 5 agosto 2025, Haleon plc (HLN) ha presentato un modulo 6-K confermando l'esecuzione della seconda tranche del programma di riacquisto azionario annunciato il 31 luglio 2025. Il 4 agosto 2025 la società ha riacquistato 1.418.324 azioni ordinarie alla Borsa di Londra per la cancellazione. I prezzi di acquisto sono variati da 355,90p a 364,60p, con una media ponderata per volume di 358,534p. Dopo la liquidazione, il capitale sociale emesso è pari a 8.984.952.236 azioni da £0,01 ciascuna; 3.880.205 azioni sono detenute in portafoglio, lasciando 8.981.072.031 azioni con diritto di voto. Un registro dettagliato delle operazioni è disponibile tramite il link LSE RNS e sul sito degli investitori di Haleon. Non sono stati forniti ulteriori risultati finanziari o indicazioni future.

El 5 de agosto de 2025, Haleon plc (HLN) presentó un Formulario 6-K confirmando la ejecución del segundo tramo de su programa de recompra de acciones anunciado el 31 de julio de 2025. El 4 de agosto de 2025, la compañía recompró 1.418.324 acciones ordinarias en la Bolsa de Londres para su cancelación. Los precios de compra oscilaron entre 355,90p y 364,60p, con un promedio ponderado por volumen de 358,534p. Tras la liquidación, el capital social emitido asciende a 8.984.952.236 acciones de £0,01 cada una; 3.880.205 acciones se mantienen en tesorería, quedando 8.981.072.031 acciones con derecho a voto. Un registro detallado de las operaciones está disponible a través del enlace LSE RNS y en el sitio para inversores de Haleon. No se proporcionaron resultados financieros adicionales ni previsiones futuras.

2025� 8� 5�, Haleon plc(HLN)� 2025� 7� 31� 발표� 자사� 매입 프로그램 � 번째 분할 실행� 확인하는 Form 6-K� 제출했습니다. 2025� 8� 4� 회사� 런던 증권거래소에� 1,418,324주의 보통주를 취소� 위해 다시 매입했습니다. 매입 가격은 355.90펜스에서 364.60펜스 사이였으며, 거래� 가� 평균 가격은 358.534펜스였습니�. 결제 � 발행 주식 수는 각각 £0.01� 8,984,952,236주이�, 3,880,205주는 자사주로 보유 중이�, 의결권이 있는 주식은 8,981,072,031주입니다. 상세 거래 내역은 LSE RNS 링크와 Haleon 투자� 사이트에� 확인� � 있습니다. 추가 재무 결과� 향후 전망은 제공되지 않았습니�.

Le 5 août 2025, Haleon plc (HLN) a déposé un formulaire 6-K confirmant l'exécution de la deuxième tranche de son programme de rachat d'actions annoncé le 31 juillet 2025. Le 4 août 2025, la société a racheté 1 418 324 actions ordinaires à la Bourse de Londres en vue de leur annulation. Les prix d'achat variaient de 355,90p à 364,60p, avec une moyenne pondérée par volume de 358,534p. Après règlement, le capital social émis s'élève à 8 984 952 236 actions de 0,01 £ chacune ; 3 880 205 actions sont détenues en trésorerie, laissant 8 981 072 031 actions avec droit de vote. Un registre détaillé des transactions est disponible via le lien LSE RNS et sur le site des investisseurs de Haleon. Aucun résultat financier supplémentaire ni indication prospective n'ont été fournis.

Am 5. August 2025 reichte Haleon plc (HLN) ein Formular 6-K ein, das die Ausführung der zweiten Tranche seines am 31. Juli 2025 angekündigten Aktienrückkaufprogramms bestätigt. Am 4. August 2025 erwarb das Unternehmen 1.418.324 Stammaktien an der Londoner Börse zum Zweck der Stornierung zurück. Die Kaufpreise lagen zwischen 355,90p und 364,60p, mit einem volumen-gewichteten Durchschnitt von 358,534p. Nach der Abwicklung beträgt das ausgegebene Grundkapital 8.984.952.236 Aktien mit einem Nennwert von je £0,01; 3.880.205 Aktien werden als eigene Aktien gehalten, sodass 8.981.072.031 stimmberechtigte Aktien verbleiben. Ein detailliertes Handelsprotokoll ist über den LSE RNS-Link und auf der Investorenseite von Haleon verfügbar. Weitere Finanzergebnisse oder Zukunftsaussagen wurden nicht veröffentlicht.

Positive
  • Execution of second-tranche buyback demonstrates ongoing capital-return commitment
  • Cancellation of shares reduces outstanding voting stock, marginally supporting EPS
Negative
  • Scale is immaterial�1.4 M shares equal just 0.016% of float, limiting financial impact
  • Cash outflow for buyback not accompanied by disclosure on funding or leverage effects

Insights

TL;DR: Minor buyback; 1.4 M shares retired—immaterial to EPS, but signals ongoing shareholder-return policy.

The repurchase equals roughly 0.016% of Haleon’s 9 B share base, so immediate EPS accretion is negligible. Nevertheless, it demonstrates management’s commitment to the July 2025 buyback plan and provides incremental support to the share price. Cash deployment is modest; no impact on leverage metrics disclosed. Overall, this is a routine capital-allocation action with limited valuation effect.

TL;DR: Filing meets UK MAR disclosure rules; share count update aids transparency.

The 6-K satisfies Article 5 UK MAR by publishing full trade details and refreshed voting-rights figure. Transparency helps investors track threshold crossings under FCA DTR 5. There are no governance red flags and the company continues to use authorised capital efficiently. Impact on control dynamics is de minimis given the tiny percentage repurchased.

Il 5 agosto 2025, Haleon plc (HLN) ha presentato un modulo 6-K confermando l'esecuzione della seconda tranche del programma di riacquisto azionario annunciato il 31 luglio 2025. Il 4 agosto 2025 la società ha riacquistato 1.418.324 azioni ordinarie alla Borsa di Londra per la cancellazione. I prezzi di acquisto sono variati da 355,90p a 364,60p, con una media ponderata per volume di 358,534p. Dopo la liquidazione, il capitale sociale emesso è pari a 8.984.952.236 azioni da £0,01 ciascuna; 3.880.205 azioni sono detenute in portafoglio, lasciando 8.981.072.031 azioni con diritto di voto. Un registro dettagliato delle operazioni è disponibile tramite il link LSE RNS e sul sito degli investitori di Haleon. Non sono stati forniti ulteriori risultati finanziari o indicazioni future.

El 5 de agosto de 2025, Haleon plc (HLN) presentó un Formulario 6-K confirmando la ejecución del segundo tramo de su programa de recompra de acciones anunciado el 31 de julio de 2025. El 4 de agosto de 2025, la compañía recompró 1.418.324 acciones ordinarias en la Bolsa de Londres para su cancelación. Los precios de compra oscilaron entre 355,90p y 364,60p, con un promedio ponderado por volumen de 358,534p. Tras la liquidación, el capital social emitido asciende a 8.984.952.236 acciones de £0,01 cada una; 3.880.205 acciones se mantienen en tesorería, quedando 8.981.072.031 acciones con derecho a voto. Un registro detallado de las operaciones está disponible a través del enlace LSE RNS y en el sitio para inversores de Haleon. No se proporcionaron resultados financieros adicionales ni previsiones futuras.

2025� 8� 5�, Haleon plc(HLN)� 2025� 7� 31� 발표� 자사� 매입 프로그램 � 번째 분할 실행� 확인하는 Form 6-K� 제출했습니다. 2025� 8� 4� 회사� 런던 증권거래소에� 1,418,324주의 보통주를 취소� 위해 다시 매입했습니다. 매입 가격은 355.90펜스에서 364.60펜스 사이였으며, 거래� 가� 평균 가격은 358.534펜스였습니�. 결제 � 발행 주식 수는 각각 £0.01� 8,984,952,236주이�, 3,880,205주는 자사주로 보유 중이�, 의결권이 있는 주식은 8,981,072,031주입니다. 상세 거래 내역은 LSE RNS 링크와 Haleon 투자� 사이트에� 확인� � 있습니다. 추가 재무 결과� 향후 전망은 제공되지 않았습니�.

Le 5 août 2025, Haleon plc (HLN) a déposé un formulaire 6-K confirmant l'exécution de la deuxième tranche de son programme de rachat d'actions annoncé le 31 juillet 2025. Le 4 août 2025, la société a racheté 1 418 324 actions ordinaires à la Bourse de Londres en vue de leur annulation. Les prix d'achat variaient de 355,90p à 364,60p, avec une moyenne pondérée par volume de 358,534p. Après règlement, le capital social émis s'élève à 8 984 952 236 actions de 0,01 £ chacune ; 3 880 205 actions sont détenues en trésorerie, laissant 8 981 072 031 actions avec droit de vote. Un registre détaillé des transactions est disponible via le lien LSE RNS et sur le site des investisseurs de Haleon. Aucun résultat financier supplémentaire ni indication prospective n'ont été fournis.

Am 5. August 2025 reichte Haleon plc (HLN) ein Formular 6-K ein, das die Ausführung der zweiten Tranche seines am 31. Juli 2025 angekündigten Aktienrückkaufprogramms bestätigt. Am 4. August 2025 erwarb das Unternehmen 1.418.324 Stammaktien an der Londoner Börse zum Zweck der Stornierung zurück. Die Kaufpreise lagen zwischen 355,90p und 364,60p, mit einem volumen-gewichteten Durchschnitt von 358,534p. Nach der Abwicklung beträgt das ausgegebene Grundkapital 8.984.952.236 Aktien mit einem Nennwert von je £0,01; 3.880.205 Aktien werden als eigene Aktien gehalten, sodass 8.981.072.031 stimmberechtigte Aktien verbleiben. Ein detailliertes Handelsprotokoll ist über den LSE RNS-Link und auf der Investorenseite von Haleon verfügbar. Weitere Finanzergebnisse oder Zukunftsaussagen wurden nicht veröffentlicht.

UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of August 2025
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F
 
Form 40-F
 
 
 
EXHIBIT INDEX
 
Exhibit Number
Description
99.1
05 August 2025 - “Transaction in Own Shares”
 
 
 
 
99.1
 
 
Haleon plc: Transaction in own shares
 
05 August 2025: Haleon plc (the "Company" or "Haleon") today announces the purchase of 1,418,324 ordinary shares of £0.01 each in the Company (the "Shares") for cancellation under the second tranche of its share buyback programme announced on 31 July 2025.
 
 
London Stock Exchange
CBOE (UK)/BXE
CBOE (UK)/CXE
Date of purchase:
04 August 2025
04 August 2025
04 August 2025
Number of Shares purchased:
1,418,324
-
-
Highest price paid per Share (p):
364.6000
-
-
Lowest price paid per Share (p):
355.9000
-
-
Volume weighted average price paid per Share (p):
358.5340
-
-
 
Following the settlement of the above, the Company's registered share capital is 8,984,952,236 ordinary shares of £0.01 each, of which 3,880,205 are held as treasury shares. Therefore, the number of ordinary shares with voting rights is 8,981,072,031 and this figure may be used by shareholders to determine if they are required to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules.
 
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades is available at the link below: 
 
http://www.rns-pdf.londonstockexchange.com/rns/9219T_1-2025-8-4.pdf 
 
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
 
This announcement and individual trade breakdown will also be available on the Company's website at: www.haleon.com/investors.
 
Enquiries
 
 
Investors
Media
 
Jo Russell  
+44 7787 392441
Zoë Bird
+44 7736 746167
Rakesh Patel     
+44 7552 484646
Victoria Durman
+44 7894 505730
 
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.
 
For more information, please visit www.haleon.com

SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
HALEON PLC
(Registrant)
 
Date: August 05, 2025
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary

FAQ

How many Haleon (HLN) shares were repurchased on 04 Aug 2025?

1,418,324 ordinary shares were bought on the London Stock Exchange for cancellation.

What was the volume-weighted average price paid per HLN share?

The VWAP was 358.534 pence per share.

How many voting shares does Haleon have after the buyback?

The company now has 8,981,072,031 ordinary shares with voting rights.

Is this buyback part of a larger programme?

Yes. It forms part of the second tranche of the share-buyback programme announced on 31 Jul 2025.

Where can investors find the detailed trade breakdown?

A full list of individual trades is available at the LSE RNS link http://www.rns-pdf.londonstockexchange.com/rns/9219T_1-2025-8-4.pdf and on Haleon’s investor website.
Haleon

NYSE:HLN

HLN Rankings

HLN Latest News

HLN Latest SEC Filings

HLN Stock Data

43.59B
4.47B
0.02%
12.82%
0.39%
Drug Manufacturers - Specialty & Generic
Healthcare
United Kingdom
Weybridge